2 shots per year cut HIV infection risk by 96%
Results from a new clinical trial indicate that the twice-yearly drug Lenacapavir offers a 96% reduced risk of new HIV infection. For oral medications that prevent new HIV infection to…
Results from a new clinical trial indicate that the twice-yearly drug Lenacapavir offers a 96% reduced risk of new HIV infection. For oral medications that prevent new HIV infection to…